Syllable

San Francisco, United States Founded: 2016 • Age: 10 yrs
AI-based digital assistants for healthcare communication are provided.

About Syllable

Syllable is a Technology company based in San Francisco (United States) founded in 2016 by Sarel Jooste and Adam Spanbauer. AI-based digital assistants for healthcare communication are provided. It operates in the Technology and Healthcare sectors. Syllable has raised $85.6 million across 4 funding rounds from investors including Verily, TCV and Oak HC/FT. Syllable has completed 1 acquisition, including Actium Health. Its chief executive, as recorded, is Kobus Jooste. Its Indian entity Stackbots Technology Private Limited reported revenue of β‚Ή31.3 Lakh. Syllable offers products and services including Agent Builder, Prompt Editor, and Audio Channel Support. Its focus areas include High Tech, Chatbots, Industry Specific and Hospitals And Clinics. Its competitors include Sensely, Vital and Loyal; 3 of its 3 listed competitors have raised funding.

Company details

Founded in 2016 and based in San Francisco, United States, Syllable operates in the healthcare AI sector. AI-driven tools, including the Voice Assistant, Web Assistant, and COVID-19 Vaccine Command Center, are developed for patient interactions. Natural language processing and machine learning models are utilized to deliver information and services through websites or mobile apps. Ontologies covering physician specialties, human diseases, and medical conditions are also maintained.

Key Metrics
  • Indian entity revenue
    ₹31.3 Lakh

    FY 2024 · -51% YoY

  • Indian entity net loss
    -₹62.6 Lakh

    FY 2024 · -200% margin

  • Indian entity EBITDA
    -₹62.7 Lakh

    FY 2024 · -200% margin

  • Total Equity Funding
    $85.6M (USD)

    in 4 rounds

  • Latest Funding Round
    $40M (USD), Series C

    Apr 2022

  • Investors
    Verily

    & 3 more

  • Investments & Acquisitions

Products & Services of Syllable

Syllable offers a comprehensive portfolio of products and services, including Agent Builder, Prompt Editor, and Audio Channel Support.

Agent Builder
AI Development Tool

Platform for building voice AI agents for call centers.

Prompt Editor
AI Interface Tool

Editor for creating and managing AI prompts easily.

Audio Channel Support
Communication Tool

System for handling voice calls via SIP or PSTN.

Funding Insights of Syllable

Syllable has successfully raised a total of $85.6M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $40 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $85.6M
  • Total Rounds 4
  • Last Round Series C β€” $40M
  • First Round $4.3M

    (Mar 2017)

  • Investors Count 4

All 4 funding rounds of Syllable with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2022$40MSeries C–TCV
Jun 2021$28MSeries B–Oak HC/FT
Sep 2018$13.3MSeries A––
–
Mar 2017$4.3MSeed––
–
Valuation history

4 investors in total: 4 institutional.

Investors in Syllable

Syllable has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Verily, TCV and Oak HC/FT.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital is invested in global technology companies by TCV.
tcv.comMenlo Park, United States
Investments are made in early-stage healthtech and fintech startups.
oakhcft.comStamford, United States
Tech startups are funded by S32, a venture capital entity.
s32.comSunnyvale, United States
AI-based solutions for health management are provided.
2015verily.comDallas, United States
Premium access

Investor details for Syllable

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Stackbots Technology Private Limited (Syllable)

Stackbots Technology Private Limited is the primary company behind Syllable. The board of Stackbots Technology Private Limited currently have 3 directors; the longest-serving is Guilherme Medeiros Bastos, appointed in 2017. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Guilherme Medeiros Bastos
DIN 06443816
Director13 Oct 20179 yrsStackbots Technology Private Limited
Kasimshetty Praveenkumar Nikitha
DIN 08198148
Director10 Jul 20197 yrs 4 moStackbots Technology Private Limited
Kasimsetty Balaramaiahsetty Mohankumar
DIN 07956057
Director02 Jun 20251 yr 5 moStackbots Technology Private Limited

People of Syllable

31 people are tracked at Syllable (12 in leadership, 5 in board & advisors, 14 in team).

NameRoleGroup
Sarel Jooste
Co-FounderLeadership
Adam Spanbauer
Co-FounderLeadership
Kobus Jooste
CEOLeadership
Tom Truong
VP, Development & OperationsLeadership
Irene Ma
Director, Finance & OperationsLeadership
Huy Tran
VP, People Ops & Diversity, Equity & InclusionLeadership
Adam Silverman
Chief Medical OfficerLeadership
Raphael Cendrillon
Chief AI OfficerLeadership
Carter Dunn
Chief Product OfficerLeadership
Jacob Brauer
Vice President, EngineeringLeadership
Amy Hand
Vp, Client SuccessLeadership
Ibrahim Cotran
VP Of ProductLeadership
Vignesh Chandramouli
Board MemberBoard & advisors
Angela Lai
Board MemberBoard & advisors
Esther Dyson
AdvisorBoard & advisors
Rick Schlesinger
AdvisorBoard & advisors
Jed McCaleb
AdvisorBoard & advisors
Brian Carlson
Principal EngineerTeam
Eric Ung
Senior AccountantTeam
Christopher Zheng
Product ManagerTeam

11 more people are available in the full profile.

Premium access

Complete people profiles for Syllable

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Syllable

Figures of Stackbots Technology Private Limited, the primary company behind Syllable, for FY 2024. Revenue was ₹31.3 Lakh (-51% year on year). Net loss was -₹62.6 Lakh (-200% margin). EBITDA was -₹62.7 Lakh (-200% margin). Revenue has grown at a compounded annual rate of -33% over three years and -23% over five years.

  • ₹31.3 LakhRevenue · FY 2024 · -51% YoY
  • -₹62.6 LakhNet loss · -200% margin
  • -₹62.7 LakhEBITDA · -200% margin
  • ₹1 LakhPaid-up capital
  • -33%Revenue CAGR, 3 years
  • -23%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Stackbots Technology Private Limited are on its company page.

Premium access

Detailed financial statements for Syllable

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Syllable

Syllable has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Actium Health.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
AI-powered marketing solutions are delivered for healthcare providers.
actiumhealth.comPalo Alto, United States2014Mar 2024β€’β€’β€’β€’
Premium access

Complete acquisition details for Syllable

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Syllable

4 dated milestones of Syllable across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Syllable is founded.
  2. Funding First funding round of $4.3M.
  3. Funding Latest funding round, Series C, of $40.0M.
  4. Acquisition Acquires Actium Health.

Competitors of Syllable

Syllable has 3 listed competitors in our database, 3 of them funded. They include Sensely, Vital and Loyal.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
sensely.com2013San Francisco, United States$26.48M9
Conversational AI platforms are developed for enterprise healthcare and insurance.
vital.io2017Claymont, United States$44.9M
Vital is recognized for patient experience technology in healthcare.
loyalhealth.com2015Atlanta, United States$46M113
Loyal is recognized as a leading digital healthcare platform.
Premium access

Detailed competitors of Syllable

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Syllable

The website of Syllable (syllable.ai) receives about 7.8K visits a month.

  • Monthly visits
    7.8K

    ▼ 9.7% vs previous month

Similar websites

Websites whose visitors overlap most with Syllable. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
chargemommybooks.com
chargemommybooks.com
100%
#1,846,160–

Top companies in Chatbots

3 companies that operate in the same segment as Syllable (Chatbots) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Cloud-based omnichannel communication and customer engagement platform is utilized.
2008San Francisco, California, United StatesUSD 239.77 MUSD 5.07 B5,540
Cloud-based business process management suite solutions are delivered.
2010San Mateo, California, United StatesUSD 400.05 MUSD 838.81 M4,500
Sierra is focused on enhancing customer experiences through AI technology.
2023San Francisco, California, United StatesUSD 1.59 B1,107
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Syllable

Premium access

Complete news archive for Syllable

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Syllable

Syllable was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Syllable is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Kobus Jooste is the CEO of Syllable, as recorded in our data.

Syllable is a funded company, having raised a total of $85.6M across 4 funding rounds to date. The company's 1st funding round was a Seed of $4.3M, raised on Mar 2017.

The primary company behind Syllable, Stackbots Technology Private Limited, reported revenue of β‚Ή31.3 Lakh for FY 2024, down 51% year on year.

Founded in 2016 and based in San Francisco, United States, Syllable operates in the healthcare AI sector. AI-driven tools, including the Voice Assistant, Web Assistant, and COVID-19 Vaccine Command Center, are developed for patient interactions. Natural language processing and machine learning models are utilized to deliver information and services through websites or mobile apps. Ontologies covering physician specialties, human diseases, and medical conditions are also maintained.

Syllable's top competitors include Loyal, Sensely and Vital.

Syllable offers Agent Builder, Prompt Editor, and Audio Channel Support.

Syllable has made 1 acquisition, including Actium Health.

Syllable has 4 investors. Key investors include Verily, TCV, Oak HC/FT, and S32.

Syllable operates through Stackbots Technology Private Limited.

The legal entities of Syllable currently have 3 directors, including Guilherme Medeiros Bastos, Kasimshetty Praveenkumar Nikitha, Kasimsetty Balaramaiahsetty Mohankumar.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available